TNC and neoplasm: Tenascin-C (TNC), an extracellular matrix molecule protein, activates Wnt/β-catenin signaling via downregulation of DKK1, a Wnt pathway inhibitor, thereby promoting pNET cell survival, angiogenic switch, tumor progression, and lung micrometastasis in RIP-Tag2 mice [327].